CHEN MICHAEL CUNYUAN (Chief Scientific Officer) reported 1 transaction at SEAPORT THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 5/4/2026ACC: 0001193125-26-204471
Officer· Chief Scientific Officer
Since Apr 2026
+56.51K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
67.03K acquired · 10.53K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+3.35K
Price / share
—
Trade value
—
% of position
New position
5/4/2026
0.00→3.35K
Total
Net shares
+3.35K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/4/2026 | C · Conversion | +3.35K | — | — | New position | 0.00 | 3.35K |
| Total | +3.35K | $0.00 | ||||||
Derivative Transactions2
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
63.68K shares
Shares
+63.68K
Strike price
18
Held after
63.68K
Exercisable
—
4/30/2026
Series B Preferred Stock
Direct
Converts to
Common Stock
3.35K shares
Shares
−10.53K
Strike price
Held after
0.00
Exercisable
—
5/4/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock63.68K shares | 4/30/2026 | A · Award | +63.68K | 18 | — | 63.68K |
| Series B Preferred Stock Direct | Common Stock3.35K shares | 5/4/2026 | C · Conversion | −10.53K | — | 0.00 |